364 related articles for article (PubMed ID: 17922444)
1. [Recent advances in the prevention of cardiovascular morbidity and mortality in end-stage renal disease: role of anemia, hyperparathyroidism and calcifications].
Del Vecchio L; Pozzoni P; Limardo M; Caruso S; Fortunato M; Pontoriero G; Locatelli F
G Ital Nefrol; 2007; 24 Suppl 38():25-32. PubMed ID: 17922444
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
Portolés J; López-Gómez JM; Aljama P
Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular calcification in nondialyzed patients with chronic kidney disease.
Qunibi WY
Semin Dial; 2007; 20(2):134-8. PubMed ID: 17374087
[TBL] [Abstract][Full Text] [Related]
5. The need for better control of secondary hyperparathyroidism.
Locatelli F
Nephrol Dial Transplant; 2004 Aug; 19 Suppl 5():V15-19. PubMed ID: 15284355
[TBL] [Abstract][Full Text] [Related]
6. Effects of calcium on cardiovascular events in patients with kidney disease and in a healthy population.
West SL; Swan VJ; Jamal SA
Clin J Am Soc Nephrol; 2010 Jan; 5 Suppl 1():S41-7. PubMed ID: 20089502
[TBL] [Abstract][Full Text] [Related]
7. [Hyperphosphatemia and cardiovascular risk in patients on dialysis].
Basić-Jukić N; Kes P
Acta Med Croatica; 2004; 58(3):207-13. PubMed ID: 15503684
[TBL] [Abstract][Full Text] [Related]
8. [Why do patients with kidney diseases end up with a heart of stone? Disturbances in calcium-phosphate balance and chronic inflammation important causes].
Martola L; Elinder CG; Stenvinkel P
Lakartidningen; 2003 Dec; 100(50):4180-3. PubMed ID: 14717005
[TBL] [Abstract][Full Text] [Related]
9. Vascular calcification and ESRD: a hard target.
Bhan I; Thadhani R
Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S102-5. PubMed ID: 19995990
[TBL] [Abstract][Full Text] [Related]
10. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.
Block GA; Klassen PS; Lazarus JM; Ofsthun N; Lowrie EG; Chertow GM
J Am Soc Nephrol; 2004 Aug; 15(8):2208-18. PubMed ID: 15284307
[TBL] [Abstract][Full Text] [Related]
11. [Cardiovascular calcification and accelerated atherosclerosis in chronic kidney disease].
Cozzolino M; Butti A; Chiarelli G; Rocca-Rey L; Santagostino G; Gallieni M; Brancaccio D
Ital Heart J Suppl; 2005 Jan; 6(1):25-8. PubMed ID: 15776728
[TBL] [Abstract][Full Text] [Related]
12. Mineral metabolism disturbances in patients with chronic kidney disease.
Kestenbaum B; Belozeroff V
Eur J Clin Invest; 2007 Aug; 37(8):607-22. PubMed ID: 17635571
[TBL] [Abstract][Full Text] [Related]
13. Challenges in the therapy of secondary hyperparathyroidism.
Wood C; González EA; Martin KJ
Ther Apher Dial; 2005 Feb; 9(1):4-8. PubMed ID: 15828898
[TBL] [Abstract][Full Text] [Related]
14. Contribution of bone and mineral abnormalities to cardiovascular disease in patients with chronic kidney disease.
Raggi P; Kleerekoper M
Clin J Am Soc Nephrol; 2008 May; 3(3):836-43. PubMed ID: 18322050
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease in the dialysis population: prognostic significance of arterial disorders.
Guérin AP; Pannier B; Marchais SJ; London GM
Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):105-10. PubMed ID: 16481874
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients.
Sit D; Kadiroglu AK; Yilmaz ME; Kara IH; Isikoglu B
Ren Fail; 2005; 27(4):403-7. PubMed ID: 16060127
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of secondary hyperparathyroidism in dialysis patients].
Di Luca M
G Ital Nefrol; 2009; 26 Suppl 49():S36-48. PubMed ID: 19941277
[TBL] [Abstract][Full Text] [Related]
18. Japanese Society of Dialysis Therapy treatment guidelines for secondary hyperparathyroidism.
Kazama JJ
Ther Apher Dial; 2007 Oct; 11 Suppl 1():S44-7. PubMed ID: 17976085
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?
Fabbri G; Maggioni AP
Adv Ther; 2009 May; 26(5):469-87. PubMed ID: 19444394
[TBL] [Abstract][Full Text] [Related]
20. [Prevention of extraskeletal calcifications in uremia].
Cozzolino M; Galassi A; Bellasi A; Butti A; Zoni U; Gallieni M; Brancaccio D
G Ital Nefrol; 2005; 22 Suppl 31():S53-5. PubMed ID: 15786403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
